The Medicinal Use of Cannabis and Cannabinoids—An International Cross-Sectional Survey on Administration Forms
Top Cited Papers
- 1 July 2013
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Psychoactive Drugs
- Vol. 45 (3), 199-210
- https://doi.org/10.1080/02791072.2013.805976
Abstract
Cannabinoids, including tetrahydrocannabinol and cannabidiol, are the most important active constituents of the cannabis plant. Over recent years, cannabinoid-based medicines (CBMs) have become increasingly available to patients in many countries, both as pharmaceutical products and as herbal cannabis (marijuana). While there seems to be a demand for multiple cannabinoid-based therapeutic products, specifically for symptomatic amelioration in chronic diseases, therapeutic effects of different CBMs have only been directly compared in a few clinical studies. The survey presented here was performed by the International Association for Cannabinoid Medicines (IACM), and is meant to contribute to the understanding of cannabinoid-based medicine by asking patients who used cannabis or cannabinoids detailed questions about their experiences with different methods of intake. The survey was completed by 953 participants from 31 countries, making this the largest international survey on a wide variety of users of cannabinoid-based medicine performed so far. In general, herbal non-pharmaceutical CBMs received higher appreciation scores by participants than pharmaceutical products containing cannabinoids. However, the number of patients who reported experience with pharmaceutical products was low, limiting conclusions on preferences. Nevertheless, the reported data may be useful for further development of safe and effective medications based on cannabis and single cannabinoids.Keywords
This publication has 28 references indexed in Scilit:
- Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposesPhytochemistry, 2010
- Marijuana Effectiveness as an HIV Self-Care StrategyClinical Nursing Research, 2009
- Dronabinol and Marijuana in HIV-Positive Marijuana SmokersJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Cannabis tea revisited: A systematic evaluation of the cannabinoid composition of cannabis teaJournal of Ethnopharmacology, 2007
- Cannabis use in patients with multiple sclerosisMultiple Sclerosis Journal, 2006
- Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinolJournal of Pharmaceutical Sciences, 2006
- The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS)International Urogynecology Journal, 2006
- Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and moodPsychopharmacology, 2005
- Pharmacokinetics and Pharmacodynamics of CannabinoidsClinical Pharmacokinetics, 2003
- Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agentsAIDS, 2001